Correlation Between Protalix Biotherapeutics and Alphabet

Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Alphabet at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Alphabet into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protalix Biotherapeutics and Alphabet Inc Class A, you can compare the effects of market volatilities on Protalix Biotherapeutics and Alphabet and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Alphabet. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Alphabet.

Diversification Opportunities for Protalix Biotherapeutics and Alphabet

-0.73

Correlation Coefficient

Protalix Biotherapeutics  Alphabet

Pay attention - limited upside

The 3 months correlation between Protalix and Alphabet is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Alphabet Inc Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alphabet Class A and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Alphabet. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alphabet Class A has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Alphabet go up and down completely randomly.

Pair Corralation between Protalix Biotherapeutics and Alphabet

Considering the 90-day investment horizon Protalix Biotherapeutics is expected to under-perform the Alphabet. In addition to that, Protalix Biotherapeutics is 1.88 times more volatile than Alphabet Inc Class A. It trades about -0.08 of its total potential returns per unit of risk. Alphabet Inc Class A is currently generating about 0.05 per unit of volatility. If you would invest  15,219  in Alphabet Inc Class A on January 26, 2024 and sell it today you would earn a total of  694.00  from holding Alphabet Inc Class A or generate 4.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Protalix Biotherapeutics  vs.  Alphabet Inc Class A

Protalix Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Protalix Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Alphabet Class A

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Alphabet Inc Class A are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent technical and fundamental indicators, Alphabet is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Protalix Biotherapeutics and Alphabet

The main advantage of trading using opposite Protalix Biotherapeutics and Alphabet positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Alphabet can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alphabet will offset losses from the drop in Alphabet's long position.

The idea behind Protalix Biotherapeutics and Alphabet Inc Class A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.